Christopher L. Reading
Directeur Technique/Scientifique/R&D chez Harbor Therapeutics, Inc.
Fortune : 16 939 $ au 31/05/2024
Postes actifs de Christopher L. Reading
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Harbor Therapeutics, Inc.
 Harbor Therapeutics, Inc. BiotechnologyHealth Technology Harbor Therapeutics, Inc. develops a proprietary class of adrenal steroid hormones as novel pharmaceuticals and nutraceuticals for human health. The company is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/01/1999 | - |
Historique de carrière de Christopher L. Reading
Anciens postes connus de Christopher L. Reading
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Corporate Officer/Principal | - | - |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Corporate Officer/Principal | - | - |
| HARBOR DIVERSIFIED, INC. | Directeur Technique/Scientifique/R&D | 01/01/1999 | - |
Formation de Christopher L. Reading
| University of California, Berkeley | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HARBOR DIVERSIFIED, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Harbor Therapeutics, Inc.
Harbor Therapeutics, Inc. BiotechnologyHealth Technology Harbor Therapeutics, Inc. develops a proprietary class of adrenal steroid hormones as novel pharmaceuticals and nutraceuticals for human health. The company is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Christopher L. Reading
- Expérience
